Crossmark

Gastroenterology Fellow Knowledge of Esophageal Motility and Manometry: Assessment and Improvement Initiative at an Academic Center

Published Online: 2025-02-14

Published Print: 2025-04

Authors

Abdel Jalil, Ala A. https://orcid.org/0000-0003-4011-3125
Koo, Thai Hau https://orcid.org/0009-0003-6671-0929
Marshall, John B.

Fass, Ronnie https://orcid.org/0000-0002-4807-3052
License Information

Text and Data Mining valid from 2025-02-14

Version of Record valid from 2025-02-14
More Information

Article History

Received: 30 December 2024

Accepted: 29 January 2025

First Online: 14 February 2025

Declarations

:

: Ronnie Fass: Advisor—Takeda, Phathom Pharmaceuticals, GERDCare, Celexio, Dexcal, Carnot, Syneos, GIE Medical, BrainTree Labs/Sebela, Renexxion. Speaker: AstraZeneca, Takeda, Eisai Pharmaceuticals, Medicamenta, Carnot, Daewoong. The remaining author did not have any conflict of interest to declare.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional and/or National Research Committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Missouri-Columbia Research Ethics Committee.

: The participant has consented to the submission of the manuscript to the journal.

: Informed consent was obtained from all individual participants included in the study.

Document is current